Global Cas12 Nuclease Market Growth 2026-2032
The global Cas12 Nuclease market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Cas12 nuclease is a type of RNA-guided enzyme derived from the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) system. It functions as a programmable endonuclease that can recognize and cleave double-stranded DNA at specific sites guided by a single RNA molecule, known as CRISPR RNA (crRNA). Cas12 is notable for its collateral cleavage activity, allowing it to cut nearby single-stranded DNA, making it useful for various applications in gene editing, diagnostics, and synthetic biology.
United States market for Cas12 Nuclease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cas12 Nuclease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cas12 Nuclease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cas12 Nuclease players cover Integrated DNA Technologies, Synthego, Danaher, GenScript, Sigma-Aldrich, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cas12 Nuclease Industry Forecast” looks at past sales and reviews total world Cas12 Nuclease sales in 2025, providing a comprehensive analysis by region and market sector of projected Cas12 Nuclease sales for 2026 through 2032. With Cas12 Nuclease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cas12 Nuclease industry.
This Insight Report provides a comprehensive analysis of the global Cas12 Nuclease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cas12 Nuclease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cas12 Nuclease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cas12 Nuclease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cas12 Nuclease.
This report presents a comprehensive overview, market shares, and growth opportunities of Cas12 Nuclease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cas12 Nuclease market?
What factors are driving Cas12 Nuclease market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cas12 Nuclease market opportunities vary by end market size?
How does Cas12 Nuclease break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Cas12 nuclease is a type of RNA-guided enzyme derived from the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) system. It functions as a programmable endonuclease that can recognize and cleave double-stranded DNA at specific sites guided by a single RNA molecule, known as CRISPR RNA (crRNA). Cas12 is notable for its collateral cleavage activity, allowing it to cut nearby single-stranded DNA, making it useful for various applications in gene editing, diagnostics, and synthetic biology.
United States market for Cas12 Nuclease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cas12 Nuclease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cas12 Nuclease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cas12 Nuclease players cover Integrated DNA Technologies, Synthego, Danaher, GenScript, Sigma-Aldrich, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cas12 Nuclease Industry Forecast” looks at past sales and reviews total world Cas12 Nuclease sales in 2025, providing a comprehensive analysis by region and market sector of projected Cas12 Nuclease sales for 2026 through 2032. With Cas12 Nuclease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cas12 Nuclease industry.
This Insight Report provides a comprehensive analysis of the global Cas12 Nuclease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cas12 Nuclease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cas12 Nuclease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cas12 Nuclease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cas12 Nuclease.
This report presents a comprehensive overview, market shares, and growth opportunities of Cas12 Nuclease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Cas12a
- Cas12b
- Other
- Academic & Research Institutes
- Biopharmaceutical
- Hospitals & Diagnostic Centers
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Integrated DNA Technologies
- Synthego
- Danaher
- GenScript
- Sigma-Aldrich
- Signalchem
- BPS Bioscience
- New England Biolabs
- Intact Genomics
- Molecular Cloning Laboratories
- Yeasen Biotechnology
- Beyotime Biotech
What is the 10-year outlook for the global Cas12 Nuclease market?
What factors are driving Cas12 Nuclease market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cas12 Nuclease market opportunities vary by end market size?
How does Cas12 Nuclease break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cas12 Nuclease Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cas12 Nuclease by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cas12 Nuclease by Country/Region, 2021, 2025 & 2032
2.2 Cas12 Nuclease Segment by Type
2.2.1 Cas12a
2.2.2 Cas12b
2.2.3 Other
2.2.4 Cas12 Nuclease Sales by Type
2.2.4.1 Global Cas12 Nuclease Sales Market Share by Type (2021-2026)
2.2.4.2 Global Cas12 Nuclease Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Cas12 Nuclease Sale Price by Type (2021-2026)
2.3 Cas12 Nuclease Segment by Application
2.3.1 Academic & Research Institutes
2.3.2 Biopharmaceutical
2.3.3 Hospitals & Diagnostic Centers
2.3.4 Other
2.3.5 Cas12 Nuclease Sales by Application
2.3.5.1 Global Cas12 Nuclease Sale Market Share by Application (2021-2026)
2.3.5.2 Global Cas12 Nuclease Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Cas12 Nuclease Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cas12 Nuclease Breakdown Data by Company
3.1.1 Global Cas12 Nuclease Annual Sales by Company (2021-2026)
3.1.2 Global Cas12 Nuclease Sales Market Share by Company (2021-2026)
3.2 Global Cas12 Nuclease Annual Revenue by Company (2021-2026)
3.2.1 Global Cas12 Nuclease Revenue by Company (2021-2026)
3.2.2 Global Cas12 Nuclease Revenue Market Share by Company (2021-2026)
3.3 Global Cas12 Nuclease Sale Price by Company
3.4 Key Manufacturers Cas12 Nuclease Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cas12 Nuclease Product Location Distribution
3.4.2 Players Cas12 Nuclease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CAS12 NUCLEASE BY GEOGRAPHIC REGION
4.1 World Historic Cas12 Nuclease Market Size by Geographic Region (2021-2026)
4.1.1 Global Cas12 Nuclease Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cas12 Nuclease Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cas12 Nuclease Market Size by Country/Region (2021-2026)
4.2.1 Global Cas12 Nuclease Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cas12 Nuclease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cas12 Nuclease Sales Growth
4.4 APAC Cas12 Nuclease Sales Growth
4.5 Europe Cas12 Nuclease Sales Growth
4.6 Middle East & Africa Cas12 Nuclease Sales Growth
5 AMERICAS
5.1 Americas Cas12 Nuclease Sales by Country
5.1.1 Americas Cas12 Nuclease Sales by Country (2021-2026)
5.1.2 Americas Cas12 Nuclease Revenue by Country (2021-2026)
5.2 Americas Cas12 Nuclease Sales by Type (2021-2026)
5.3 Americas Cas12 Nuclease Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cas12 Nuclease Sales by Region
6.1.1 APAC Cas12 Nuclease Sales by Region (2021-2026)
6.1.2 APAC Cas12 Nuclease Revenue by Region (2021-2026)
6.2 APAC Cas12 Nuclease Sales by Type (2021-2026)
6.3 APAC Cas12 Nuclease Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cas12 Nuclease by Country
7.1.1 Europe Cas12 Nuclease Sales by Country (2021-2026)
7.1.2 Europe Cas12 Nuclease Revenue by Country (2021-2026)
7.2 Europe Cas12 Nuclease Sales by Type (2021-2026)
7.3 Europe Cas12 Nuclease Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cas12 Nuclease by Country
8.1.1 Middle East & Africa Cas12 Nuclease Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cas12 Nuclease Revenue by Country (2021-2026)
8.2 Middle East & Africa Cas12 Nuclease Sales by Type (2021-2026)
8.3 Middle East & Africa Cas12 Nuclease Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cas12 Nuclease
10.3 Manufacturing Process Analysis of Cas12 Nuclease
10.4 Industry Chain Structure of Cas12 Nuclease
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cas12 Nuclease Distributors
11.3 Cas12 Nuclease Customer
12 WORLD FORECAST REVIEW FOR CAS12 NUCLEASE BY GEOGRAPHIC REGION
12.1 Global Cas12 Nuclease Market Size Forecast by Region
12.1.1 Global Cas12 Nuclease Forecast by Region (2027-2032)
12.1.2 Global Cas12 Nuclease Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cas12 Nuclease Forecast by Type (2027-2032)
12.7 Global Cas12 Nuclease Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Integrated DNA Technologies
13.1.1 Integrated DNA Technologies Company Information
13.1.2 Integrated DNA Technologies Cas12 Nuclease Product Portfolios and Specifications
13.1.3 Integrated DNA Technologies Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Integrated DNA Technologies Main Business Overview
13.1.5 Integrated DNA Technologies Latest Developments
13.2 Synthego
13.2.1 Synthego Company Information
13.2.2 Synthego Cas12 Nuclease Product Portfolios and Specifications
13.2.3 Synthego Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Synthego Main Business Overview
13.2.5 Synthego Latest Developments
13.3 Danaher
13.3.1 Danaher Company Information
13.3.2 Danaher Cas12 Nuclease Product Portfolios and Specifications
13.3.3 Danaher Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Danaher Main Business Overview
13.3.5 Danaher Latest Developments
13.4 GenScript
13.4.1 GenScript Company Information
13.4.2 GenScript Cas12 Nuclease Product Portfolios and Specifications
13.4.3 GenScript Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GenScript Main Business Overview
13.4.5 GenScript Latest Developments
13.5 Sigma-Aldrich
13.5.1 Sigma-Aldrich Company Information
13.5.2 Sigma-Aldrich Cas12 Nuclease Product Portfolios and Specifications
13.5.3 Sigma-Aldrich Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sigma-Aldrich Main Business Overview
13.5.5 Sigma-Aldrich Latest Developments
13.6 Signalchem
13.6.1 Signalchem Company Information
13.6.2 Signalchem Cas12 Nuclease Product Portfolios and Specifications
13.6.3 Signalchem Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Signalchem Main Business Overview
13.6.5 Signalchem Latest Developments
13.7 BPS Bioscience
13.7.1 BPS Bioscience Company Information
13.7.2 BPS Bioscience Cas12 Nuclease Product Portfolios and Specifications
13.7.3 BPS Bioscience Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BPS Bioscience Main Business Overview
13.7.5 BPS Bioscience Latest Developments
13.8 New England Biolabs
13.8.1 New England Biolabs Company Information
13.8.2 New England Biolabs Cas12 Nuclease Product Portfolios and Specifications
13.8.3 New England Biolabs Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 New England Biolabs Main Business Overview
13.8.5 New England Biolabs Latest Developments
13.9 Intact Genomics
13.9.1 Intact Genomics Company Information
13.9.2 Intact Genomics Cas12 Nuclease Product Portfolios and Specifications
13.9.3 Intact Genomics Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Intact Genomics Main Business Overview
13.9.5 Intact Genomics Latest Developments
13.10 Molecular Cloning Laboratories
13.10.1 Molecular Cloning Laboratories Company Information
13.10.2 Molecular Cloning Laboratories Cas12 Nuclease Product Portfolios and Specifications
13.10.3 Molecular Cloning Laboratories Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Molecular Cloning Laboratories Main Business Overview
13.10.5 Molecular Cloning Laboratories Latest Developments
13.11 Yeasen Biotechnology
13.11.1 Yeasen Biotechnology Company Information
13.11.2 Yeasen Biotechnology Cas12 Nuclease Product Portfolios and Specifications
13.11.3 Yeasen Biotechnology Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Yeasen Biotechnology Main Business Overview
13.11.5 Yeasen Biotechnology Latest Developments
13.12 Beyotime Biotech
13.12.1 Beyotime Biotech Company Information
13.12.2 Beyotime Biotech Cas12 Nuclease Product Portfolios and Specifications
13.12.3 Beyotime Biotech Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beyotime Biotech Main Business Overview
13.12.5 Beyotime Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cas12 Nuclease Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cas12 Nuclease by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cas12 Nuclease by Country/Region, 2021, 2025 & 2032
2.2 Cas12 Nuclease Segment by Type
2.2.1 Cas12a
2.2.2 Cas12b
2.2.3 Other
2.2.4 Cas12 Nuclease Sales by Type
2.2.4.1 Global Cas12 Nuclease Sales Market Share by Type (2021-2026)
2.2.4.2 Global Cas12 Nuclease Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Cas12 Nuclease Sale Price by Type (2021-2026)
2.3 Cas12 Nuclease Segment by Application
2.3.1 Academic & Research Institutes
2.3.2 Biopharmaceutical
2.3.3 Hospitals & Diagnostic Centers
2.3.4 Other
2.3.5 Cas12 Nuclease Sales by Application
2.3.5.1 Global Cas12 Nuclease Sale Market Share by Application (2021-2026)
2.3.5.2 Global Cas12 Nuclease Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Cas12 Nuclease Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cas12 Nuclease Breakdown Data by Company
3.1.1 Global Cas12 Nuclease Annual Sales by Company (2021-2026)
3.1.2 Global Cas12 Nuclease Sales Market Share by Company (2021-2026)
3.2 Global Cas12 Nuclease Annual Revenue by Company (2021-2026)
3.2.1 Global Cas12 Nuclease Revenue by Company (2021-2026)
3.2.2 Global Cas12 Nuclease Revenue Market Share by Company (2021-2026)
3.3 Global Cas12 Nuclease Sale Price by Company
3.4 Key Manufacturers Cas12 Nuclease Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cas12 Nuclease Product Location Distribution
3.4.2 Players Cas12 Nuclease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CAS12 NUCLEASE BY GEOGRAPHIC REGION
4.1 World Historic Cas12 Nuclease Market Size by Geographic Region (2021-2026)
4.1.1 Global Cas12 Nuclease Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cas12 Nuclease Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cas12 Nuclease Market Size by Country/Region (2021-2026)
4.2.1 Global Cas12 Nuclease Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cas12 Nuclease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cas12 Nuclease Sales Growth
4.4 APAC Cas12 Nuclease Sales Growth
4.5 Europe Cas12 Nuclease Sales Growth
4.6 Middle East & Africa Cas12 Nuclease Sales Growth
5 AMERICAS
5.1 Americas Cas12 Nuclease Sales by Country
5.1.1 Americas Cas12 Nuclease Sales by Country (2021-2026)
5.1.2 Americas Cas12 Nuclease Revenue by Country (2021-2026)
5.2 Americas Cas12 Nuclease Sales by Type (2021-2026)
5.3 Americas Cas12 Nuclease Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cas12 Nuclease Sales by Region
6.1.1 APAC Cas12 Nuclease Sales by Region (2021-2026)
6.1.2 APAC Cas12 Nuclease Revenue by Region (2021-2026)
6.2 APAC Cas12 Nuclease Sales by Type (2021-2026)
6.3 APAC Cas12 Nuclease Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cas12 Nuclease by Country
7.1.1 Europe Cas12 Nuclease Sales by Country (2021-2026)
7.1.2 Europe Cas12 Nuclease Revenue by Country (2021-2026)
7.2 Europe Cas12 Nuclease Sales by Type (2021-2026)
7.3 Europe Cas12 Nuclease Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cas12 Nuclease by Country
8.1.1 Middle East & Africa Cas12 Nuclease Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cas12 Nuclease Revenue by Country (2021-2026)
8.2 Middle East & Africa Cas12 Nuclease Sales by Type (2021-2026)
8.3 Middle East & Africa Cas12 Nuclease Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cas12 Nuclease
10.3 Manufacturing Process Analysis of Cas12 Nuclease
10.4 Industry Chain Structure of Cas12 Nuclease
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cas12 Nuclease Distributors
11.3 Cas12 Nuclease Customer
12 WORLD FORECAST REVIEW FOR CAS12 NUCLEASE BY GEOGRAPHIC REGION
12.1 Global Cas12 Nuclease Market Size Forecast by Region
12.1.1 Global Cas12 Nuclease Forecast by Region (2027-2032)
12.1.2 Global Cas12 Nuclease Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cas12 Nuclease Forecast by Type (2027-2032)
12.7 Global Cas12 Nuclease Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Integrated DNA Technologies
13.1.1 Integrated DNA Technologies Company Information
13.1.2 Integrated DNA Technologies Cas12 Nuclease Product Portfolios and Specifications
13.1.3 Integrated DNA Technologies Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Integrated DNA Technologies Main Business Overview
13.1.5 Integrated DNA Technologies Latest Developments
13.2 Synthego
13.2.1 Synthego Company Information
13.2.2 Synthego Cas12 Nuclease Product Portfolios and Specifications
13.2.3 Synthego Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Synthego Main Business Overview
13.2.5 Synthego Latest Developments
13.3 Danaher
13.3.1 Danaher Company Information
13.3.2 Danaher Cas12 Nuclease Product Portfolios and Specifications
13.3.3 Danaher Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Danaher Main Business Overview
13.3.5 Danaher Latest Developments
13.4 GenScript
13.4.1 GenScript Company Information
13.4.2 GenScript Cas12 Nuclease Product Portfolios and Specifications
13.4.3 GenScript Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GenScript Main Business Overview
13.4.5 GenScript Latest Developments
13.5 Sigma-Aldrich
13.5.1 Sigma-Aldrich Company Information
13.5.2 Sigma-Aldrich Cas12 Nuclease Product Portfolios and Specifications
13.5.3 Sigma-Aldrich Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sigma-Aldrich Main Business Overview
13.5.5 Sigma-Aldrich Latest Developments
13.6 Signalchem
13.6.1 Signalchem Company Information
13.6.2 Signalchem Cas12 Nuclease Product Portfolios and Specifications
13.6.3 Signalchem Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Signalchem Main Business Overview
13.6.5 Signalchem Latest Developments
13.7 BPS Bioscience
13.7.1 BPS Bioscience Company Information
13.7.2 BPS Bioscience Cas12 Nuclease Product Portfolios and Specifications
13.7.3 BPS Bioscience Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BPS Bioscience Main Business Overview
13.7.5 BPS Bioscience Latest Developments
13.8 New England Biolabs
13.8.1 New England Biolabs Company Information
13.8.2 New England Biolabs Cas12 Nuclease Product Portfolios and Specifications
13.8.3 New England Biolabs Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 New England Biolabs Main Business Overview
13.8.5 New England Biolabs Latest Developments
13.9 Intact Genomics
13.9.1 Intact Genomics Company Information
13.9.2 Intact Genomics Cas12 Nuclease Product Portfolios and Specifications
13.9.3 Intact Genomics Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Intact Genomics Main Business Overview
13.9.5 Intact Genomics Latest Developments
13.10 Molecular Cloning Laboratories
13.10.1 Molecular Cloning Laboratories Company Information
13.10.2 Molecular Cloning Laboratories Cas12 Nuclease Product Portfolios and Specifications
13.10.3 Molecular Cloning Laboratories Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Molecular Cloning Laboratories Main Business Overview
13.10.5 Molecular Cloning Laboratories Latest Developments
13.11 Yeasen Biotechnology
13.11.1 Yeasen Biotechnology Company Information
13.11.2 Yeasen Biotechnology Cas12 Nuclease Product Portfolios and Specifications
13.11.3 Yeasen Biotechnology Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Yeasen Biotechnology Main Business Overview
13.11.5 Yeasen Biotechnology Latest Developments
13.12 Beyotime Biotech
13.12.1 Beyotime Biotech Company Information
13.12.2 Beyotime Biotech Cas12 Nuclease Product Portfolios and Specifications
13.12.3 Beyotime Biotech Cas12 Nuclease Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beyotime Biotech Main Business Overview
13.12.5 Beyotime Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cas12 Nuclease Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cas12 Nuclease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cas12a
Table 4. Major Players of Cas12b
Table 5. Major Players of Other
Table 6. Global Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 7. Global Cas12 Nuclease Sales Market Share by Type (2021-2026)
Table 8. Global Cas12 Nuclease Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cas12 Nuclease Revenue Market Share by Type (2021-2026)
Table 10. Global Cas12 Nuclease Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Cas12 Nuclease Sale by Application (2021-2026) & (K Units)
Table 12. Global Cas12 Nuclease Sale Market Share by Application (2021-2026)
Table 13. Global Cas12 Nuclease Revenue by Application (2021-2026) & ($ million)
Table 14. Global Cas12 Nuclease Revenue Market Share by Application (2021-2026)
Table 15. Global Cas12 Nuclease Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Cas12 Nuclease Sales by Company (2021-2026) & (K Units)
Table 17. Global Cas12 Nuclease Sales Market Share by Company (2021-2026)
Table 18. Global Cas12 Nuclease Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Cas12 Nuclease Revenue Market Share by Company (2021-2026)
Table 20. Global Cas12 Nuclease Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Cas12 Nuclease Producing Area Distribution and Sales Area
Table 22. Players Cas12 Nuclease Products Offered
Table 23. Cas12 Nuclease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cas12 Nuclease Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Cas12 Nuclease Sales Market Share Geographic Region (2021-2026)
Table 28. Global Cas12 Nuclease Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Cas12 Nuclease Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Cas12 Nuclease Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Cas12 Nuclease Sales Market Share by Country/Region (2021-2026)
Table 32. Global Cas12 Nuclease Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cas12 Nuclease Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cas12 Nuclease Sales by Country (2021-2026) & (K Units)
Table 35. Americas Cas12 Nuclease Sales Market Share by Country (2021-2026)
Table 36. Americas Cas12 Nuclease Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 38. Americas Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 39. APAC Cas12 Nuclease Sales by Region (2021-2026) & (K Units)
Table 40. APAC Cas12 Nuclease Sales Market Share by Region (2021-2026)
Table 41. APAC Cas12 Nuclease Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 43. APAC Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 44. Europe Cas12 Nuclease Sales by Country (2021-2026) & (K Units)
Table 45. Europe Cas12 Nuclease Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 47. Europe Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Cas12 Nuclease Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Cas12 Nuclease Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Cas12 Nuclease
Table 53. Key Market Challenges & Risks of Cas12 Nuclease
Table 54. Key Industry Trends of Cas12 Nuclease
Table 55. Cas12 Nuclease Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cas12 Nuclease Distributors List
Table 58. Cas12 Nuclease Customer List
Table 59. Global Cas12 Nuclease Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Cas12 Nuclease Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Cas12 Nuclease Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Cas12 Nuclease Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Cas12 Nuclease Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Cas12 Nuclease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Cas12 Nuclease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Cas12 Nuclease Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Cas12 Nuclease Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Cas12 Nuclease Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Cas12 Nuclease Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Integrated DNA Technologies Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 74. Integrated DNA Technologies Cas12 Nuclease Product Portfolios and Specifications
Table 75. Integrated DNA Technologies Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Integrated DNA Technologies Main Business
Table 77. Integrated DNA Technologies Latest Developments
Table 78. Synthego Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 79. Synthego Cas12 Nuclease Product Portfolios and Specifications
Table 80. Synthego Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Synthego Main Business
Table 82. Synthego Latest Developments
Table 83. Danaher Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 84. Danaher Cas12 Nuclease Product Portfolios and Specifications
Table 85. Danaher Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Danaher Main Business
Table 87. Danaher Latest Developments
Table 88. GenScript Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 89. GenScript Cas12 Nuclease Product Portfolios and Specifications
Table 90. GenScript Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. GenScript Main Business
Table 92. GenScript Latest Developments
Table 93. Sigma-Aldrich Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 94. Sigma-Aldrich Cas12 Nuclease Product Portfolios and Specifications
Table 95. Sigma-Aldrich Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Sigma-Aldrich Main Business
Table 97. Sigma-Aldrich Latest Developments
Table 98. Signalchem Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 99. Signalchem Cas12 Nuclease Product Portfolios and Specifications
Table 100. Signalchem Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Signalchem Main Business
Table 102. Signalchem Latest Developments
Table 103. BPS Bioscience Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 104. BPS Bioscience Cas12 Nuclease Product Portfolios and Specifications
Table 105. BPS Bioscience Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BPS Bioscience Main Business
Table 107. BPS Bioscience Latest Developments
Table 108. New England Biolabs Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 109. New England Biolabs Cas12 Nuclease Product Portfolios and Specifications
Table 110. New England Biolabs Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. New England Biolabs Main Business
Table 112. New England Biolabs Latest Developments
Table 113. Intact Genomics Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 114. Intact Genomics Cas12 Nuclease Product Portfolios and Specifications
Table 115. Intact Genomics Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Intact Genomics Main Business
Table 117. Intact Genomics Latest Developments
Table 118. Molecular Cloning Laboratories Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 119. Molecular Cloning Laboratories Cas12 Nuclease Product Portfolios and Specifications
Table 120. Molecular Cloning Laboratories Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Molecular Cloning Laboratories Main Business
Table 122. Molecular Cloning Laboratories Latest Developments
Table 123. Yeasen Biotechnology Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 124. Yeasen Biotechnology Cas12 Nuclease Product Portfolios and Specifications
Table 125. Yeasen Biotechnology Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Yeasen Biotechnology Main Business
Table 127. Yeasen Biotechnology Latest Developments
Table 128. Beyotime Biotech Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 129. Beyotime Biotech Cas12 Nuclease Product Portfolios and Specifications
Table 130. Beyotime Biotech Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Beyotime Biotech Main Business
Table 132. Beyotime Biotech Latest Developments
Table 1. Cas12 Nuclease Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cas12 Nuclease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cas12a
Table 4. Major Players of Cas12b
Table 5. Major Players of Other
Table 6. Global Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 7. Global Cas12 Nuclease Sales Market Share by Type (2021-2026)
Table 8. Global Cas12 Nuclease Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cas12 Nuclease Revenue Market Share by Type (2021-2026)
Table 10. Global Cas12 Nuclease Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Cas12 Nuclease Sale by Application (2021-2026) & (K Units)
Table 12. Global Cas12 Nuclease Sale Market Share by Application (2021-2026)
Table 13. Global Cas12 Nuclease Revenue by Application (2021-2026) & ($ million)
Table 14. Global Cas12 Nuclease Revenue Market Share by Application (2021-2026)
Table 15. Global Cas12 Nuclease Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Cas12 Nuclease Sales by Company (2021-2026) & (K Units)
Table 17. Global Cas12 Nuclease Sales Market Share by Company (2021-2026)
Table 18. Global Cas12 Nuclease Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Cas12 Nuclease Revenue Market Share by Company (2021-2026)
Table 20. Global Cas12 Nuclease Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Cas12 Nuclease Producing Area Distribution and Sales Area
Table 22. Players Cas12 Nuclease Products Offered
Table 23. Cas12 Nuclease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cas12 Nuclease Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Cas12 Nuclease Sales Market Share Geographic Region (2021-2026)
Table 28. Global Cas12 Nuclease Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Cas12 Nuclease Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Cas12 Nuclease Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Cas12 Nuclease Sales Market Share by Country/Region (2021-2026)
Table 32. Global Cas12 Nuclease Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cas12 Nuclease Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cas12 Nuclease Sales by Country (2021-2026) & (K Units)
Table 35. Americas Cas12 Nuclease Sales Market Share by Country (2021-2026)
Table 36. Americas Cas12 Nuclease Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 38. Americas Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 39. APAC Cas12 Nuclease Sales by Region (2021-2026) & (K Units)
Table 40. APAC Cas12 Nuclease Sales Market Share by Region (2021-2026)
Table 41. APAC Cas12 Nuclease Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 43. APAC Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 44. Europe Cas12 Nuclease Sales by Country (2021-2026) & (K Units)
Table 45. Europe Cas12 Nuclease Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 47. Europe Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Cas12 Nuclease Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Cas12 Nuclease Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Cas12 Nuclease Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Cas12 Nuclease Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Cas12 Nuclease
Table 53. Key Market Challenges & Risks of Cas12 Nuclease
Table 54. Key Industry Trends of Cas12 Nuclease
Table 55. Cas12 Nuclease Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cas12 Nuclease Distributors List
Table 58. Cas12 Nuclease Customer List
Table 59. Global Cas12 Nuclease Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Cas12 Nuclease Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Cas12 Nuclease Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Cas12 Nuclease Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Cas12 Nuclease Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Cas12 Nuclease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Cas12 Nuclease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Cas12 Nuclease Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Cas12 Nuclease Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Cas12 Nuclease Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Cas12 Nuclease Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Integrated DNA Technologies Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 74. Integrated DNA Technologies Cas12 Nuclease Product Portfolios and Specifications
Table 75. Integrated DNA Technologies Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Integrated DNA Technologies Main Business
Table 77. Integrated DNA Technologies Latest Developments
Table 78. Synthego Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 79. Synthego Cas12 Nuclease Product Portfolios and Specifications
Table 80. Synthego Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Synthego Main Business
Table 82. Synthego Latest Developments
Table 83. Danaher Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 84. Danaher Cas12 Nuclease Product Portfolios and Specifications
Table 85. Danaher Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Danaher Main Business
Table 87. Danaher Latest Developments
Table 88. GenScript Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 89. GenScript Cas12 Nuclease Product Portfolios and Specifications
Table 90. GenScript Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. GenScript Main Business
Table 92. GenScript Latest Developments
Table 93. Sigma-Aldrich Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 94. Sigma-Aldrich Cas12 Nuclease Product Portfolios and Specifications
Table 95. Sigma-Aldrich Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Sigma-Aldrich Main Business
Table 97. Sigma-Aldrich Latest Developments
Table 98. Signalchem Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 99. Signalchem Cas12 Nuclease Product Portfolios and Specifications
Table 100. Signalchem Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Signalchem Main Business
Table 102. Signalchem Latest Developments
Table 103. BPS Bioscience Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 104. BPS Bioscience Cas12 Nuclease Product Portfolios and Specifications
Table 105. BPS Bioscience Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BPS Bioscience Main Business
Table 107. BPS Bioscience Latest Developments
Table 108. New England Biolabs Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 109. New England Biolabs Cas12 Nuclease Product Portfolios and Specifications
Table 110. New England Biolabs Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. New England Biolabs Main Business
Table 112. New England Biolabs Latest Developments
Table 113. Intact Genomics Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 114. Intact Genomics Cas12 Nuclease Product Portfolios and Specifications
Table 115. Intact Genomics Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Intact Genomics Main Business
Table 117. Intact Genomics Latest Developments
Table 118. Molecular Cloning Laboratories Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 119. Molecular Cloning Laboratories Cas12 Nuclease Product Portfolios and Specifications
Table 120. Molecular Cloning Laboratories Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Molecular Cloning Laboratories Main Business
Table 122. Molecular Cloning Laboratories Latest Developments
Table 123. Yeasen Biotechnology Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 124. Yeasen Biotechnology Cas12 Nuclease Product Portfolios and Specifications
Table 125. Yeasen Biotechnology Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Yeasen Biotechnology Main Business
Table 127. Yeasen Biotechnology Latest Developments
Table 128. Beyotime Biotech Basic Information, Cas12 Nuclease Manufacturing Base, Sales Area and Its Competitors
Table 129. Beyotime Biotech Cas12 Nuclease Product Portfolios and Specifications
Table 130. Beyotime Biotech Cas12 Nuclease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Beyotime Biotech Main Business
Table 132. Beyotime Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cas12 Nuclease
Figure 2. Cas12 Nuclease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cas12 Nuclease Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Cas12 Nuclease Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cas12 Nuclease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cas12 Nuclease Sales Market Share by Country/Region (2025)
Figure 10. Cas12 Nuclease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cas12a
Figure 12. Product Picture of Cas12b
Figure 13. Product Picture of Other
Figure 14. Global Cas12 Nuclease Sales Market Share by Type in 2026
Figure 15. Global Cas12 Nuclease Revenue Market Share by Type (2021-2026)
Figure 16. Cas12 Nuclease Consumed in Academic & Research Institutes
Figure 17. Global Cas12 Nuclease Market: Academic & Research Institutes (2021-2026) & (K Units)
Figure 18. Cas12 Nuclease Consumed in Biopharmaceutical
Figure 19. Global Cas12 Nuclease Market: Biopharmaceutical (2021-2026) & (K Units)
Figure 20. Cas12 Nuclease Consumed in Hospitals & Diagnostic Centers
Figure 21. Global Cas12 Nuclease Market: Hospitals & Diagnostic Centers (2021-2026) & (K Units)
Figure 22. Cas12 Nuclease Consumed in Other
Figure 23. Global Cas12 Nuclease Market: Other (2021-2026) & (K Units)
Figure 24. Global Cas12 Nuclease Sale Market Share by Application (2025)
Figure 25. Global Cas12 Nuclease Revenue Market Share by Application in 2026
Figure 26. Cas12 Nuclease Sales by Company in 2026 (K Units)
Figure 27. Global Cas12 Nuclease Sales Market Share by Company in 2026
Figure 28. Cas12 Nuclease Revenue by Company in 2026 ($ millions)
Figure 29. Global Cas12 Nuclease Revenue Market Share by Company in 2026
Figure 30. Global Cas12 Nuclease Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Cas12 Nuclease Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 33. Americas Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 34. APAC Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 35. APAC Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 36. Europe Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 37. Europe Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 40. Americas Cas12 Nuclease Sales Market Share by Country in 2026
Figure 41. Americas Cas12 Nuclease Revenue Market Share by Country (2021-2026)
Figure 42. Americas Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 43. Americas Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 44. United States Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Cas12 Nuclease Sales Market Share by Region in 2026
Figure 49. APAC Cas12 Nuclease Revenue Market Share by Region (2021-2026)
Figure 50. APAC Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 51. APAC Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 52. China Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 56. India Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Cas12 Nuclease Sales Market Share by Country in 2026
Figure 60. Europe Cas12 Nuclease Revenue Market Share by Country (2021-2026)
Figure 61. Europe Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 62. Europe Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 63. Germany Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 64. France Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Cas12 Nuclease Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 71. Egypt Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Cas12 Nuclease in 2026
Figure 77. Manufacturing Process Analysis of Cas12 Nuclease
Figure 78. Industry Chain Structure of Cas12 Nuclease
Figure 79. Channels of Distribution
Figure 80. Global Cas12 Nuclease Sales Market Forecast by Region (2027-2032)
Figure 81. Global Cas12 Nuclease Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Cas12 Nuclease Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Cas12 Nuclease Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Cas12 Nuclease Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Cas12 Nuclease Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Cas12 Nuclease
Figure 2. Cas12 Nuclease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cas12 Nuclease Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Cas12 Nuclease Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cas12 Nuclease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cas12 Nuclease Sales Market Share by Country/Region (2025)
Figure 10. Cas12 Nuclease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cas12a
Figure 12. Product Picture of Cas12b
Figure 13. Product Picture of Other
Figure 14. Global Cas12 Nuclease Sales Market Share by Type in 2026
Figure 15. Global Cas12 Nuclease Revenue Market Share by Type (2021-2026)
Figure 16. Cas12 Nuclease Consumed in Academic & Research Institutes
Figure 17. Global Cas12 Nuclease Market: Academic & Research Institutes (2021-2026) & (K Units)
Figure 18. Cas12 Nuclease Consumed in Biopharmaceutical
Figure 19. Global Cas12 Nuclease Market: Biopharmaceutical (2021-2026) & (K Units)
Figure 20. Cas12 Nuclease Consumed in Hospitals & Diagnostic Centers
Figure 21. Global Cas12 Nuclease Market: Hospitals & Diagnostic Centers (2021-2026) & (K Units)
Figure 22. Cas12 Nuclease Consumed in Other
Figure 23. Global Cas12 Nuclease Market: Other (2021-2026) & (K Units)
Figure 24. Global Cas12 Nuclease Sale Market Share by Application (2025)
Figure 25. Global Cas12 Nuclease Revenue Market Share by Application in 2026
Figure 26. Cas12 Nuclease Sales by Company in 2026 (K Units)
Figure 27. Global Cas12 Nuclease Sales Market Share by Company in 2026
Figure 28. Cas12 Nuclease Revenue by Company in 2026 ($ millions)
Figure 29. Global Cas12 Nuclease Revenue Market Share by Company in 2026
Figure 30. Global Cas12 Nuclease Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Cas12 Nuclease Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 33. Americas Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 34. APAC Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 35. APAC Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 36. Europe Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 37. Europe Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Cas12 Nuclease Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Cas12 Nuclease Revenue 2021-2026 ($ millions)
Figure 40. Americas Cas12 Nuclease Sales Market Share by Country in 2026
Figure 41. Americas Cas12 Nuclease Revenue Market Share by Country (2021-2026)
Figure 42. Americas Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 43. Americas Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 44. United States Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Cas12 Nuclease Sales Market Share by Region in 2026
Figure 49. APAC Cas12 Nuclease Revenue Market Share by Region (2021-2026)
Figure 50. APAC Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 51. APAC Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 52. China Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 56. India Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Cas12 Nuclease Sales Market Share by Country in 2026
Figure 60. Europe Cas12 Nuclease Revenue Market Share by Country (2021-2026)
Figure 61. Europe Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 62. Europe Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 63. Germany Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 64. France Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Cas12 Nuclease Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Cas12 Nuclease Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Cas12 Nuclease Sales Market Share by Application (2021-2026)
Figure 71. Egypt Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Cas12 Nuclease Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Cas12 Nuclease in 2026
Figure 77. Manufacturing Process Analysis of Cas12 Nuclease
Figure 78. Industry Chain Structure of Cas12 Nuclease
Figure 79. Channels of Distribution
Figure 80. Global Cas12 Nuclease Sales Market Forecast by Region (2027-2032)
Figure 81. Global Cas12 Nuclease Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Cas12 Nuclease Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Cas12 Nuclease Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Cas12 Nuclease Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Cas12 Nuclease Revenue Market Share Forecast by Application (2027-2032)
